AtriCure (ATRC) Market Capitalization (2010 - 2026)

AtriCure (ATRC) has reported Market Capitalization for 17 consecutive years, with $1.4 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Market Capitalization fell 12.6% year-over-year to $1.4 billion in Q2 2026; TTM through Jun 2026 was $1.4 billion, a 12.6% decrease from a year earlier, with the FY2025 full-year figure at $2.0 billion, up 31.9% from the prior year.
• Market Capitalization was $1.4 billion for Q2 2026 at AtriCure, down from $1.4 billion in the prior quarter.
• Over five years, Market Capitalization peaked at $3.0 billion in Q1 2022 and troughed at $1.1 billion in Q2 2024.
• A 5-year average of $1.8 billion and a median of $1.7 billion in 2023 frame the typical range for Market Capitalization.
• Across the five-year window, Market Capitalization sank 52.57% in 2024 and surged 46.89% in 2025, its largest moves.
• Over 5 years, Market Capitalization stood at $2.1 billion in 2022, then dropped by 17.92% to $1.7 billion in 2023, then slipped by 11.95% to $1.5 billion in 2024, then jumped by 31.9% to $2.0 billion in 2025, then fell by 27.75% to $1.4 billion in 2026.
• The last three Market Capitalization figures came in at $1.4 billion (Q2 2026), $1.4 billion (Q1 2026), and $2.0 billion (Q4 2025), per Business Quant data.